Presentation
Topics Covered
We invite you to learn more about:
- Current treatment options for patients living with ALL
- The impact of minimal residual disease (MRD)
- Clinical trials and emerging therapies for ALL treatment
- The importance of open communication with your healthcare team to promote a better quality of life
Speaker
Daniel J. DeAngelo, M.D., Ph.D.
Adult Leukemia Program
Dana-Farber Cancer Institute
Brigham and Women’s Hospital
Harvard Medical School
Boston, MA
Program Support
Support for this program provided by
For any questions or comments about this program, please email feedback@LLS.org.